Viruses conditionally replicating in cancer cells form an attractive novel class of antitumoral agents. To engineer such viruses infectivity can be coupled with proteolytic activity of the target cell by modifying the envelope (Env) protein of murine leukaemia virus (MLV) with blocking domains that prevent cell entry unless they are cleaved off by tumour-associated proteases like the matrix metalloproteases (MMP). Here we show that MLV variants selectively spreading through MMP-positive cells can be evolved from virus libraries, in which a standard MMP-2 substrate peptide connecting the blocking domain CD40L with the Env protein was diversified. Passaging the virus library on human fibrosarcoma or glioma cell lines resulted in the selection of about 10 virus clones, of which the three most frequent ones were shown to become activated by MMPs and to be replication competent on MMP-positive cells only. On these cells, the selected linker peptides improved the spreading by several orders of magnitude in vitro, as well as in tumour xenografts in vivo, approaching the kinetic of the unmodified wild-type virus. The data suggest that retroviral protease substrate libraries form a potent tool for the engineering of viruses conditionally replicating in a given cancer cell type of interest. Gene Therapy (2005) 12, 918-926.
Introduction
Selective infection of tumour cells with viruses is an attractive strategy in the fight against cancer. 1 As only very few viruses show a natural selective tropism for certain types of cancer cells, virus engineering has to be applied. This is especially true for redirecting cell entry, which is the most preferable strategy. However, the conventional approach of introducing changes into viral envelope proteins has had very limited success. 2 Therefore, intelligent systematic approaches have to be developed to achieve this goal. The selection of combinatorially diversified libraries of virus variants for selective replication in a given tumour cell line is especially attractive. Proof of principle for this approach provided by us and others demonstrated that retroviruses with altered (extended) tropism can be selected from such libraries by passage on target cells. [3] [4] [5] Our strategy for selective infection of cancer cells involves the use of protease-activatable retroviruses.
Protease dependency is achieved by displaying blocking domains, that interfere with cell entry, via protease cleavable linker peptides on the murine leukaemia virus (MLV) envelope (Env) protein. 2 Retroviral Env proteins are homotrimers composed of heterodimers formed by the surface subunit (SU) which contacts the viral receptor during cell entry, and the transmembrane subunit (TM) which anchors the Env protein complex in the viral envelope. Two types of blocking domains have been described. Growth factors, when fused to the N-terminus of SU, sequester the virus onto their receptor, thus reducing infectivity on cells overexpressing the growth factor receptor. Correspondingly, protease-activatable vectors have been engineered to display epidermal growth factor (EGF) via substrate linker peptides for factor Xa, plasmin, or matrix metalloproteases (MMPs). 6 These viruses are activatable on cells expressing both active MMPs and the EGF receptor, but their infectivity is unimpaired on EGF receptor-negative cells, due to the lack of sequestration. The second type of blocking domains prevent MLV receptor contact due to steric hindrance, thus impairing the infectivity in general, independently from the cell line used. These include the proline-rich region of MLV Env as well as trimeric ligands like the extracellular domain of CD40 ligand (CD40L). [7] [8] [9] Besides its steric interference with receptor contact, CD40L is not functionally active when displayed on MLV particles. Using an assay in which RAMOS cells are rescued from drug-induced apoptosis by contact with membranes exposing CD40L, the virus and virusinfected cells could not rescue them, whereas control cells with surface CD40L could. 10, 11 Thus, most likely due to its 'upside down' expression as type 2 transmembrane protein on the type 1 Env protein, CD40L neither triggers CD40 signalling nor binds CD40. A straightforward approach to select blocked viruses that become optimally activated is to diversify the linker peptides and then to passage the library of variant viruses on a given target cell type. From the first library based on fully randomised linker peptides and the EGFblocking domain, we had previously selected viruses activatable by the ubiquitously expressed intracellular furin-like proteases. 3 From the second generation of libraries, MMP-activatable viruses were selected. In the latter libraries key residues in the linker peptide had been randomized such that the inadvertent introduction of furin protease cleavage signals is avoided. 12 The selected MMP-activatable retroviruses showed a considerably enhanced spreading efficiency in tumour cells due to an about 10-fold enhanced cell entry kinetic and an improved susceptibility for MMP-2, which mediates the invasion of tumour cells by degradation of the extracellular matrix. 13 However, these EGF-displaying viruses are able to infect cells with low EGF receptor density at an unimpaired efficiency.
14 It is therefore impossible to restrict their tropism to MMP-positive cell types. In this study here, we have therefore generated libraries of CD40L displaying MLVs. We can show that viruses with a restricted host range for MMP-positive cells are efficiently selected on different tumour cell lines.
Results

Generation and selection of the library
In the CD40L displaying retroviral protease substrate library C-X4-A, we diversified the P2, P2 0 , and P3, P3 0 positions of the six residues of the MMP-2 cleavage site PLGkLWA (arrow indicates the cleaved peptide bond), but kept the residues P1 and P1' next to the scissile bond constant ( Figure 1 ). Electroporation of the ligation product into bacterial cells resulted in 1 Â 10 6 clones which well covered the 4 Â 10 4 theoretically encoded linker peptide variants. Restriction analysis of the plasmid library revealed that all of 16 randomly picked clones contained the diversified linker peptide encoding sequence.
For selection, HEK-293T cells were transfected with the pC-X4-A library at an estimated transfection efficiency of 50%. Sequence analysis of the released virus library demonstrated the random distribution of aminoacid residues at each of the diversified positions (28 clones sequenced, none identical; not shown). After passaging the virus library on HT1080 cells for 12 days, a clear-cut enrichment of certain linker peptide types was observed within the virus population (see Materials and methods section for details on the selection procedure). The AKGLYK/H linker was the most prominent one coming out of the selection process, with a frequency of 20% (Table 1) . Besides, seven other types of sequences occurred at frequencies between 5 and 10%, respectively. The second most frequent linker peptide PSGLYQ as well as some of the other linker peptide types fulfil the PXXkHy consensus, thus constituting likely MMP substrates. 15 Others showed no similarity to any defined protease substrate motifs. None of the clones encoded the parental PLGLWA peptide. Although this motive was not included in the original library, it might have occurred through a single-point mutation. Single-or multiple-point mutations have been observed, even in selections of nonreplicative retroviral libraries.
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The selected viruses are MMP dependent
The most frequently selected peptides on HT1080 cells, AKGLYK and PSGLYQ, were used to reconstitute the molecular virus clones C-AK-A and C-PS-A. The viruses were produced in MMP-negative HEK-293T cells and 6) . Densitometric measurement of the SU-derived bands in lanes 4 and 8 revealed a 7.3-fold enhanced cleavage efficiency of C-PS-A as compared to C-MMP-A. Thus, both selected viruses were cleaved by MMP-2 and the sensitivity of the PSGLYQ peptide was clearly improved compared to the parental peptide. Next, MMP-inhibitor assays were performed by treating HT1080 cells with GM6001, a broad-range MMP inhibitor, during infection and further cultivation. The C-PS-A and the C-MMP-A viruses were sensitive to the GM6001 treatment (Figure 2b ), while the C-AK-A virus was only slightly more affected than the WT virus.
To further demonstrate that expression of MT1-MMP, which is involved in the activation process of several other MMPs, was sufficient for activating the infectivity of the selected viruses, we used MDCK cells that were stably transfected with MT1-MMP. These MT1-MDCK as well as the MT1-MMP negative control cells were infected with the C-AK-A, C-PS-A and the WT virus. There was no general advantage for viral infectivity of MT1-MMP-expressing MDCK cells. In fact, the WT virus was slightly more infectious on the control MDCK cells. In contrast, all the selected viruses were considerably more infectious on MT1-MDCK cells (Figure 2c ).
Virus growth on different cell lines
At first, we determined the levels of active MMP-2 and MMP-9 in different cell types using gelatine zymography. The T-lymphocyte cell lines Jurkat and A3.01 were negative for any of these proteolytic activities (data not shown). Faint bands appearing at the electrophoretic mobility of the MMP-2 proform were detectable for HEK-293T, A431 and MDA-MB-468 cells (Figure 3a) . However, the MMP-2 proform is proteolytically active only in the gelatine zymography, but not in vivo. 17 Thus, these cells are negative for active MMPs, which is in agreement with previous observations. 18 The highest level of active MMP-2 was detected in U87-MG, followed by HT1080 and primary human umbilical vein endothelial cells (HUVEC) (Figure 3a ). In contrast, active MMP-9 was most prominent in HT1080, while U87-MG cells expressed moderate levels of MMP-9. Thus, cell lines containing different levels of active MMPs were available to monitor infection by the variant virus clones.
To compare the growth characteristics of the reconstituted selected viruses with that of the parental virus, we initially infected HT1080 cells with equal amounts of RT activity of each virus clone produced on HEK-293T cells, respectively. We then followed spreading of the viruses by assaying RT activity in the cell culture supernatant, and by determining the percentage of infected cells. RT-PCR performed on viral RNA confirmed the genetic stability of all the viruses over the complete period of observation (not shown). Infection with the C-A virus did not result in RT activity above background level. Although RT activity was detectable for the C-MMP-A virus, it was up to three orders of magnitudes below that of the selected viruses ( Figure 3b ). As determined by immunostaining, less than 10% of the cells were positive for the C-MMP-A virus even at day 18 past infection ( Table 2) . The selected viruses, in contrast, Interestingly, the C-AK-A virus spread considerably faster than the C-PS-A virus, reaching the steady-state level of RT activity already by day 13. All cells had become virus positive by this time point (Table 2) . Thus, the selection process had resulted in virus variants being several orders of magnitudes more efficient in spreading through HT1080 cells than the parental C-MMP-A virus. Next, we analysed the growth capabilities of all the selected viruses on all the different cell lines characterized for MMP expression. While WT MLV efficiently infected all these cell lines, none of the cells was susceptible for the C-A virus (Table 2; Figure 4a ). In sharp contrast, the MMP-cleavable viruses and the C-AK-A virus exhibited a conditional phenotype showing a clear growth dependence on the cell type used. Complete absence of virus propagation was observed for lymphocytes (Jurkat, A3.01), in which none of the CD40L-displaying viruses was detectable, neither by immunostaining nor by RT assay (Table 2 ; not shown). Although the adherent MMP-negative cell lines (MDA-MB-468, A431, 293T) showed initially a few positive cells, their numbers did not increase (Table 2 ). In agreement with this, RT activity released from these cells remained below 0.01% of the maximal levels and was just above background (not shown). In contrast, the MMP-positive HT1080, HUVEC and U87-MG cells allowed spreading of the selected viruses (Table 2 and Figures 3b, 4a) . Interestingly, the (Figure 4a ). Accordingly, it was unable to infect activated primary HUVEC cells, while this was possible for the selected viruses (Table 2) .
Cell-type-specific selection improves the spreading capability
Our data demonstrate that the spreading of MMPactivatable viruses can be strongly improved by directed evolution without compromising their restricted host range. Although the viruses that were selected on HT1080 cells were also able to spread through other MMP-positive cell lines, performing the selection directly on the cell type of interest might further improve these viruses. To test this hypothesis, the C-X4-A library was selected on U87-MG cells for 45 days. We used this rather long selection period to possibly identify the most efficient virus present in the library. Yet, to our surprise a single-virus clone was present in the cell culture supernatant after selection. Out of 28 sequenced clones all encoded the linker peptide PAGLHV, which was different from all the peptides selected on HT1080 cells, but fulfilled the PXXkHy consensus of MMP substrates. 15 Infection experiments with MT1-MMP-expressing MDCK cells confirmed the MMP dependence of the reconstituted C-HV-A virus displaying the PAGLHV linker peptide (Figure 2c) .
The spreading efficiency of the C-HV-A virus on U87-MG cells was then determined in comparison to the WT virus, the viruses selected on HT1080 cells, and the parental virus. We followed spreading by determining released RT activity (Figure 4a ) and by titrating the number of infectious particles (Table 3) . Again, the genetic integrity of all viruses throughout the complete growth period was confirmed by RT-PCR (not shown). Remarkably, the C-HV-A virus reached the same maximal level of RT units as the WT virus, already by day five. It was thus by far more efficient in spreading through U87-MG cells than the HT1080 selected viruses. Also, on U87-MG, the C-AK-A virus was more efficient than the C-PS-A virus, however, lagged about 8 days behind the C-HV-A virus to reach the WT level of RTactivity. By this time point, particles of all three selected viruses released into the cell culture medium contained partially cleaved Env proteins (Figure 4b) .
The infectious titres released from the infected cells nicely correlated with the RT data: supernatants harvested on days 3 and 7 after infection were titrated on HT1080 and U87-MG cells in parallel. For the WT virus, titres were very similar on both cell types, while for the selected viruses they were on average about two-fold higher when determined on HT1080 cells. More importantly, the C-HV-A virus produced between 10-and 100-fold more infectious virus particles per time period than the C-AK-A virus, and upto 10 4 more than the C-MMP-A virus. The endpoint titre reached was only about five times below that of the WT virus.
Spreading through tumour tissue
Taken together, the characterization of the selected viruses clearly demonstrated that the selection procedure had improved the spreading efficiency of MMP-activatable retroviruses through MMP-positive tumour cell lines. However, the spreading through a monolayer of cultivated cells may not be predictable for the spreading through solid tumour tissue. In order to determine the spreading capabilities of the selected viruses in vivo, we established a HT1080-based xenograft mouse model. Virus spreading was initially followed upon injection of mixtures of uninfected and infected HT1080 cells, and in a second step also upon virus injection into established tumours. The genomic stability of the viruses was controlled by PCR on genomic tumour tissue DNA.
Cell mixtures containing 1 or 0.2% HT1080 cells infected with the WT, C-MMP-A, C-AK-A or C-PS-A virus were injected subcutaneously (s.c.) into SCID mice, respectively. At 2 weeks p.i., tumours were removed, disaggregated and the cells cultivated in the presence of azidothymidine (AZT) to prevent any further virus spreading. Immunostaining of the cells against the viral p30 antigen revealed that in all samples 100% of the cells were virus positive. Thus, all virus types had been able to spread through the tumour tissue. However, the parental virus had lost most of the CD40L coding sequence ( Figure  5a, lanes 3 and 4) . This was the case for both tumour samples infected with the C-MMP-A virus. In contrast, the selected viruses had remained genetically stable while spreading through the tumour tissue (lanes 5-8).
To reflect more the situation in a therapeutical antitumoral approach, we injected about 10 3 i.u. of the C-AK-A virus into an established HT1080 tumour and determined the fraction of infected cells 10, 14 and 21 days after infection. By day 14, in two out of three mice up to 7% infected cells became detectable in recultivated tumour cells (Figure 5b ). By week 3, more than half of the tumour cells had become virus positive (Figure 5b) . Again, PCR on tumour DNA confirmed that the virus had retained its genetic integrity. Staining of sections through the tumour tissue revealed that the virus had spread from single infected centres (Figure 5b) . Overall, these data demonstrated that the selected viruses were able to spread efficiently though tumour tissue, thereby remaining genetically stable. The parental virus, in contrast, had to rely on deletions within the blocking domain, thus losing the conditionally replicative properties to become comparably efficient.
Discussion
Targeting viral gene transfer at the level of cell entry is still one of the most challenging topics in vector Selection of conditionally replicating viruses I Hartl et al development. Previous selections based on virus libraries using the EGF-blocking domain resulted in viruses that were MMP-dependent on EGF-receptor positive cells only. 12 Using the blocking domain CD40L, we present the first study describing the generation of retroviruses with restricted host range by molecular evolution. Starting from an MMP-activatable virus that was unable to spread completely through the fibrosarcoma cell line HT1080, our process of diversifying the linker peptide serving as protease substrate and selecting for efficient virus spreading ended up with several virus clones that were orders of magnitude more efficient in spreading than the parental virus, but retained its targeting capabilities. While HT1080 and U87-MG cells, both expressing high levels of active MMPs, became readily infected, no spreading through a variety of MMPnegative cells was detectable.
The improved spreading of the selected viruses was also verified in vivo in an HT1080 xenograft mouse tumour model. The even more restrictive in vivo conditions resulted in genetic instability of the parental virus, which was only able to propagate upon genetic deletion of the blocking domain coding sequence. The selected viruses in contrast remained genetically stable also in vivo and were able to spread through the complete tumour tissue also upon intratumoral injection. Thus, our selection process did not only improve the spreading efficiency but also the genetic stability of proteaseactivatable retroviruses.
Proteolytic activation of viruses displaying the CD40L-blocking domain is thought to occur extracellularly before the virus particles attach to their receptor. From this, as well as previous studies, it is evident that the blocking domain must be removed only from a fraction of Env molecules in a given virus particle to activate infection. 3, 12 It is, however, unclear how large this fraction exactly has to be. As the C-AK-A virus showed the lowest amounts of activated Env molecules in the supernatant of U87-MG cells but was more efficient in spreading through these cells than the C-PS-A virus, this threshold level may in fact vary with the type of linker peptide displayed. Transferred to the clinical situation, the presence of such activated viruses in circulation may be thought to reduce the cell specificity of this targeting system. However, further spreading into protease-negative tissue will be strongly restricted, as proteasenegative cells will only release blocked virus. Thus, only single infection rounds in non-target tissue could occur. Biodistribution studies in mouse tumour models will be required to determine the in vivo targeting capabilities of these viruses.
Overall, spreading of the selected viruses correlated nicely with MMP expression. Thus, the enhanced spreading capabilities did not compromise their strict MMP dependence and their physical targeting to MMPpositive cell lines. In addition, several other lines of experimental evidence proved that the selected viruses became activated by MMPs: (i) a broad-range MMP inhibitor impaired their infectivity, (ii) cleavage of the CD40L-blocking domain was observed in virus particles present in the culture supernatant of infected MMPpositive cells and upon treatment with recombinant MMP-2, (iii) MDCK cells became highly susceptible to the selected viruses upon expression of an MT1-MMP cDNA, (iv) the selected linker peptides showed strong homology to known MMP cleavage sites. The latter point holds true especially for the PAGLHV and the PSGLYQ peptide, which is closely related to the PQGLYQ peptide that was previously selected from an EGF-displaying substrate library. Both fulfilled the PXXkHy consensus of substrates susceptible to a broad range of MMPs. 12, 15 The AKGLYK peptide, in contrast, may serve as substrate of an even broader spectrum of proteases. HT1080 and U87-MG cells are known to express not only a number of different MMPs but also plasmin and the urokinase plasmin activator, both serine proteases that require positively charged residues in their substrates, which in fact are present in the AKGLYK linker peptide. 19, 20 It is well conceivable that in the end our selection procedure favoured those virus variants displaying linker peptides being cleavable by many proteases expressed by the target cell, given that the AKGLYK peptide might well serve as substrate for both MMP-2 and serine proteases like plasmin and uPA.
One of the most interesting outcomes of this study was the observation how strongly the selection is influenced by the cell type applied in the selection procedure. Selecting the same virus library on the glioma cell line U87-MG resulted in a single virus clone encoding the PAGLHV linker peptide which was not present in the virus population resulting from the selection on HT1080 cells. More remarkably, the U87-MG-selected C-HV-A virus reached almost WT virus efficiency in spreading through U87-MG cells and thus was much more effective than the C-AK-A virus selected on HT1080 cells. This illustrates nicely the power of library-based approaches Selection of conditionally replicating viruses I Hartl et al in virus engineering, which will allow fine-tuned adaptation of vector systems to a given target cell type.
Promising preclinical data on the treatment of malignant gliomas have recently been reported using replication-competent MLV vectors transferring cytotoxic genes. 21 Although the spreading of replication-competent MLV seems to be restricted to the tumour tissue, the use of replicating retroviruses in humans will definitely require several levels of safety measures to be introduced into such viruses. 22 Among these, restricting viral replication to the tumour tissue will be of highest priority.
Thus, the C-HV-A and C-AK-A viruses will be prime candidates for further development towards clinical application. Moreover, with the library approach demonstrated here for retroviruses, and recently also for adenoassociated viral vectors, the generation of individualized targeted viruses becomes conceivable if appropriate libraries are selected on a panel of different tumour cell lines or even on patient tumour biopsy material. 23 Tumour therapy can then be started having the best available targeting virus for a given tumour at hand. Beyond that, the linker peptides selected this way will also be of high value for the design of MMP-activatable toxins or cytokines. 24, 25 Materials and methods
Generation of the plasmids
Plasmids pC-A and pE-A have been described. 12 To insert protease-cleavable or diversified linker peptideencoding regions, the SfiI-NotI cassette of pC-A was exchanged against SfiI/NotI-digested PCR fragments generated with the universal primer CB6(+) 0 for pC-X4-A using pC-A as template. Degenerated codons are labelled in italics, the NotI restriction site is underlined. Ligation and cloning conditions for the library were as previously described. 12 To reconstitute the pC-HV-A plasmid, the SfiI-NotI cassette from the Topo-TA plasmid of a single sequenced bacterial clone obtained after selection of the C-X4-A library on U87-MG cells was inserted into SfiI/NotIdigested pC-A.
Unmodified amphotropic MLV was generated from a modified version of the plasmid pM91 (kindly provided by D von Laer, Frankfurt) pM91MS in which the plasmid backbone and large parts of the gag/pol genes were exchanged against that of plasmid pE-A using the SacII and PacI restriction sites. 26 MT1-MDCK were obtained by transfection of MDCK cells with an MT1-MMP cDNA cloned into the pLNCX2 expression plasmid (Invitrogen) and followed by Neomycin selection. Jurkat (human T-cell leukaemia; DMSZ, ACC 282) and A3.01 were cultivated in RPMI-1640 and U87-MG (human glioblastoma astrocytoma; ATCC, HTB-14) in EMEM. 27 All media were supplemented with 10% foetal calf serum (FCS; GIBCOt), benzylpenicillin (60 mg/ml) and streptomycin (100 mg/ml). Freshly prepared HUVEC were cultivated in MCDB 131 (GIBCOt) supplemented with 10 mM L-glutamine, 8% FCS, 100 ng/ l human EGF (PromoCell Heidelberg, Germany), 1 mg/l human bFGF (PromoCell), and Endothelial Cell Growth Supplement/Heparin (PromoCell). All cells were grown at 371C in an atmosphere of 5% CO 2 .
Selection of the virus libraries
A single 10 cm dish containing 4 Â 10 6 HEK-293T cells was transfected with 10 mg of the plasmid library using Lipofectamine Plus (GIBCOt) according to the supplier's instructions. 1 Â 10 6 HT1080 cells were seeded onto a transwell membrane (Corning, NY, USA) on the same day and were cocultivated with the transfected HEK-293T starting the day after transfection for 2 days. After 2 days, the HT1080 cells were transferred to a T75 culture flask and expanded until day 7 when 20% of the cells were cultivated to confluence by day 9. Then, 10% of the cells were mixed 1:1 with uninfected HT1080 cells. For selection on U87-MG cells cocultivation with pC-X4-Atransfected HEK-293T cells was performed from day 1 after transfection until day 4. The U87-MG cells were then further cultivated until day 45. For analysis, virus was collected from the cell supernatant by ultracentrifugation (30 000 r.p.m. for 1 h at 41C) in a SW41 rotor (Beckman, USA). RNA was purified using the QIAamp Viral RNA Mini Kit (Qiagen, Germany), followed by treatment with DNase (Qiagen).
For sequence analysis RNA was reverse transcribed into cDNA (primer EAseq1(À) 5 0 -TATAATTTTGG GAAGGCATCTTG-3 0 ), which was then amplified by PCR using CB6 and EAseq1(À). The PCR products were subcloned using the Topo-TA cloning kit (Invitrogent) and plasmid from single bacterial colonies was sequenced using the primer EAseq1.
Virus propagation and detection
To generate virus stocks, 50-70% confluent HEK-293T cells grown in T175 flasks were transfected with 28 mg viral plasmid DNA using Lipofectamine Plus (GIBCOt). At 2 days after transfection, virus-containing supernatants were filtered through a 0.45 mm sterile filter and aliquots were stored at À801C. For Western blot analysis or proteolytic digestion, viruses were harvested into serum-free DMEM. Infectious particles released from HT1080 or HEK-293T cells were quantified by immunohistochemistry using the goat anti RLV-p30 serum (Quality, Biotech), as previously described. 3 RT activity was determined using the C-type-RT Activity Assay (Cavidi Tech, Uppsala, Sweden) according to the manufacturer's instructions.
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To monitor viral growth kinetics, cells were seeded in six-well plates at 70% confluence and infected with 300 mU RT activity of the viral stocks. For the WT virus, 30 mU were used. The infected cells were cultivated for up to 4 weeks. At the given time points, the number of infected cells was determined by immunohistochemistry and quantification of RT activity.
Western blot analysis, proteolytic digestion and gelatine zymography Virus collected by ultracentrifugation from 11 ml serumfree supernatant was suspended in 100 ml of cold PBS, separated by electrophoresis on a 10% SDS-polyacrylamide gel, and electrotransferred onto a nitrocellulose membrane (Hybond ECL, Amersham). The membranes were probed with the anti-RLV-gp70 or anti-RLV-p30 goat antisera (Quality, Biotech) and incubated with HRPconjugated rabbit anti-goat antibodies (DAKO). Protein bands were visualized using ECL (Pierce).
For MMP-2 cleavage 20 ml of virus was incubated with 0.5 mg of activated MMP-2 (Chemicon, USA) in a final volume of 25 ml at 371C for 45 min and analysed by Western blot as described above.
For gelatine zymography 20 ml of conditioned cell culture medium was separated in 10% SDS-polyacrylamide gels containing 0.1% gelatine. Gels were washed in 2.5% Triton-100 (Serva, Heidelberg, Germany) for 1 h. Overnight proteolysis was performed in 50 mM Tris, pH 7.5, 200 mM NaCl, 5 mM CaCl 2 , 0.02% (w/v) Brij-35 at 371C. Gels were then stained with 0.5% Coomassie brilliant blue for 3 h and destained in 30% methanol, 10% acetic acid solution until clear bands became apparent.
Inhibition of MMP activity
HT1080 cells (1 Â 10 5 ) were seeded in a 24-well dish and on the next day infected at an MOI of 0.5 for 4 h at 371C in the presence of GM6001 (Calbiochem, USA). The cells were then washed with PBS and further cultivated for 30 h in the presence of the inhibitor. The number of infected cells was determined by immunohistochemistry.
Animal experiments
Experimental mouse work was carried out in compliance with the regulations of the German animal protection law. CB17 SCID female mice, 6 weeks old, were obtained from Charles River Laboratories (Wilmington, MA, USA) and maintained under pathogen-free conditions. Animals were acclimated for at least 1 week before the start of the study. HT1080 tumours were established by subcutaneous injections of 5 Â 10 5 tumour cells in 100 ml of PBS in the left flank of mice. For intratumoral injection of virus, 1 Â 10 3 i.u. in 50 ml PBS were injected into 14-days-old palpable HT1080 tumours. To analyse, virus-spreading mice were killed and tumours harvested. For recultivation one-third of the tumour mass was treated with collagenase for 12 h in DMEM complemented with 10 mM AZT. Cells were then further expanded in DMEM supplemented with AZT. For analysis of the viral genome, tumour DNA was extracted using the QIAamp tissue kit (Qiagen). PCR (annealing 611C, 40 cycles) was then performed using the primer pair CB6/EAseq1 for MMP-activatable viruses, and wtCB6 (5 0 -CCCTTAA TAGTCATGGGAGTCC-3 0 ) and EAseq1 for the WT MLV virus.
For the in situ detection of virus antigen, one-third of the tumour mass was snap-frozen in 2-methylbutane precooled on dry ice and stored at À801C. Frozen sections (5 mm in thickness) were cut on a cryostat and processed for immunohistochemistry by standard procedures. Sections were fixed in cold acetone for 20 min, followed by quenching of endogenous peroxidase with 0.3% H 2 O 2 in methanol (30 min, RT). Nonspecific binding was blocked with 1% BSA/PBS. Then, sections were proceeded with a two-step incubation, first with the goat anti-RLV p30 serum (Quality Biotech) at a 1:250 dilution at 371C for 1 h, followed by incubation with a 1:1000 dilution of the HRP-conjugated rabbit anti-goat antibody (DAKO).
